You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Impact Factor: 1.0 / 5-Year Impact Factor: 1.9

Journal Homepage Submission guidelines

Free access

Brief report

First published online 1992-5

Early Detection of Down's Syndrome Using Free Beta Human Choriogonadotropin

and

Volume 29, Issue 3

https://doi.org/10.1177/000456329202900319

Abstract

Keywords

alpha fetoprotein gestational age discriminant analysis

References

1.

Macri

JN

Kasturi

RV

Krantz

DA

Maternal serum Down syndrome screening: Free beta protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol 1990; 163: 1248–53.

2.

Spencer

K.

Evaluation of an assay of the free beta subunit of choriogonadotropin and its potential value in screening for Down's syndrome. Clin Chem 1991; 37: 809–14.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Free access

The Effects of Gestation Dating on the Calculation of Patient-Specific Risks in Down's Syndrome Screening: Multivariate Case

Free access

Primary Hepatocellular Carcinoma in Zimbabwe: Frequency of Abnormal Biochemical Investigations

Free access

Dual Analyte Immunoassay in Neural Tube Defect and Down's Syndrome Screening: Results of a Multicentre Clinical Trial

Free access

Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical Markers